Novartis | NVS - Creditori Commerciali





Creditori Commerciali Cambiamento Data
AbbVie USD 3.59B 28.65B 2025-12
Amgen USD 2.86B 16.65B 2026-06
AstraZeneca USD 22.89B 388M 2026-06
Bausch Health Companies USD 593M 0 2026-06
Biogen USD 403.9M 45.4M 2026-06
Bristol-Myers Squibb USD 4.16B 76M 2026-06
Canopy Growth CAD 34.82M 14.85M 2026-03
Corcept Therapeutics USD 14.91M 18.4M 2026-06
Drreddys Laboratories INR 22.36B 21.91B 2026-03
Eli Lilly USD 6.11B 1.08B 2026-06
Gilead Sciences USD 645M 70M 2026-03
GlaxoSmithKline GBP 14.34B 7M 2026-06
Glaxosmithkline GBP 14.34B 6.39B 2026-03
J&J USD 9.22B 1.24B 2026-06
Merck USD 3.83B 36M 2026-06
Novartis USD 4.26B 64M 2026-06
Novartis USD 4.32B 134M 2026-03
Pacira USD 17.51M 3.5M 2026-06
Perrigo USD 400.4M 34.4M 2026-06
Pfizer USD 4.58B 75M 2026-06
Phibro Animal Health USD 127.31M 2.33M 2026-06
Prestige Brands USD 36.85M 14.06M 2026-06
Roche Holding CHF 5.54B 237M 2026-06
Sanofi EUR 23.6B 888M 2026-06
Sanofi EUR 22.71B 219M 2026-03
Supernus Pharmaceuticals USD 5.59M 4.58M 2026-06
Zoetis USD 452M 55M 2026-06